BDBM39731 1-N,4-N-bis(4-phenylbutan-2-yl)benzene-1,4-dicarboxamide::MLS000535122::N,N'-bis(1-methyl-3-phenylpropyl)terephthalamide::N,N'-bis(1-methyl-3-phenyl-propyl)terephthalamide::N1,N4-bis(4-phenylbutan-2-yl)benzene-1,4-dicarboxamide::SMR000142555::cid_2931670

SMILES O=C(N[C@@H](c1ccccc1)c1ccc(C2CC2)c(F)n1)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(OCCOc2cn(CC(=O)N3C[C@H](F)C[C@H]3C(=O)N[C@@H](c3ccccc3)c3ccc(C4CC4)c(F)n3)nn2)nn1

InChI Key InChIKey=PIBOHJFCAFPWKW-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 39731   

TargetGlycogen [starch] synthase, muscle(Human)
Maze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 39731BDBM39731(US20260098025, Compound 9)
Affinity DataIC50: 20.1nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2026
Entry Details
US Patent